1 / 7

Connected Drug Delivery Devices Market 2021 By Industry Growth & Regional Trend

Connected drug delivery devices market revenue will grow manifold with the trend for AI and machine learning in emerging and developed economies.<br><br>Get sample copy of this research report @ https://www.gminsights.com/request-sample/detail/4422

11788
Télécharger la présentation

Connected Drug Delivery Devices Market 2021 By Industry Growth & Regional Trend

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Connected Drug Delivery Devices Market is projected to reach CAGR 35.3% by 2027

  2. Key Insights from Connected Drug Delivery Devices Market: • Connected drug delivery devices market revenue will grow manifold with the trend for AI and machine learning in emerging and developed economies. Real-time data has forayed into the healthcare sector to predict results and redefine the outlook of connected drug delivery devices. Delivering drugs through connected devices will potentially help companies maximize return on investments and boost the growth momentum. • Biopharma companies are likely to explore the commercial value of medication to emphasize outcome optimization. Leading players are expected to equip devices with sensors to leverage connections and streamline the transfer of data. In terms of revenue, connected drug delivery devices market is forecast to surpass USD 2.5 billion by 2027, reflecting a CAGR of 35.3% during the period. • End-users are likely to expand their penetration in integrated devices with the growing popularity of wearables and handheld devices. Advanced technology is sought to assist patients in managing their medication remotely, thereby helping track dosage in real-time. The integrated drug delivery devices segment was valued at around USD 196.8 in 2020 and will witness a similar trend in the coming years.

  3. Regional Insights in Connected Drug Delivery Devices Market: • The Asia Pacific will potentially be replete with investments given the unprecedented demand for advanced medical devices in India and China. Dynamics such as sedentary lifestyle, diabetes, obesity and hypertension have stimulated the demand for smart devices. Notably, the looming threat of noncommunicable diseases has compelled hospitals and clinics to invest in advanced drug delivery products. The Asia Pacific connected drug delivery devices market is likely to touch USD 387.9 million by 2027, attributed to the presence of pharmaceutical companies.

  4. Latest Research Report On Connected Drug Delivery Devices Market @ https://www.gminsights.com/industry-analysis/connected-drug-delivery-devices-market Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/4422

  5. Major Companies in Connected Drug Delivery Devices Market: • Adherium • Bayer • Merck • Phillips Medisize • Nemera • BioCorp • Findair • Propeller Health

  6. Industry Coverage

  7. Stay In Touch Website: www.gminsights.com Social Media:

More Related